JPRN-UMIN000001562已完成未知
Comparison of insulin detemir and insulin glargine on glucose variability in type 1 and type 2 diabetes. - Comparison of insulin detemir and insulin glargine.
ational Hospital Organization, Okayama Medical Center0 个研究点目标入组 30 人开始时间: 2008年12月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients who cannot record SMBG.
研究者
相似试验
进行中（未招募）
1 期
Comparison of insulin detemir and insulin glargine in patients with Type 2 diabetes - Detemir vs GlargineType 2 DiabetesEUCTR2005-004754-27-GBCardiff University12
进行中（未招募）
不适用
Impact of insulin detemir versus insulin glargine on glycaemic control and metabolism during exercise in Type 1 diabetes - Comparing long-acting insulins during exercise in Type 1 DiabetesMedDRA version: 14.0Level: PTClassification code 10067584Term: Type 1 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 1 DiabetesEUCTR2011-001209-28-GBBuckinghamshire Healthcare NHS Trust30
已完成
3 期
Comparison of Insulin Glargine and Detemir on Hormone Factors Affecting Appetite in Patients with Type 1 DiabetesType 1 Diabetes.Type 1 Diabetes mellitusIRCT20191208045651N1Iran University of Medical Sciences41
进行中（未招募）
不适用
Comparison of the effect of insulin detemir and NPH insulin on dawn phenomenon in patients with Type 1 diabetes An open-labelled, randomised, cross-over, multi-center trial comparing the effect of insulin detemir versus NPH insulin as basal insulins on dawn phenomenon and the glycaemic control in patients with Type 1 diabetes treated on a basal-bolus regimen - Dawn phenomenon – insulin detemirType 1 diabetes mellitus, dawn phenomenonEUCTR2005-003877-26-HUational Centre for Diabetes Care, 1st Dept. Medicine, Diabetes Unit
已完成
4 期
Basal Insulins - PharmacodynamicsDiabetesNCT00566124University of Aarhus10